Molina Healthcare Inc (MOH) Stock Price & How to Invest

Molina Healthcare is a Fortune 500 managed-care organization that provides health coverage almost exclusively through government-sponsored programs. It runs four segments (Medicaid, Medicare, Marketplace, and Other) and serves roughly 5.6 million members, with about 90% in Medicaid. Its model is to specialize in low-income, senior, and disabled populations, winning state Medicaid contracts and managing medical costs tightly rather than competing in commercial employer insurance. Revenue is dominated by premiums the states and federal government pay per member, so growth comes from new contract wins, acquisitions, and membership rather than pricing power.

The investment picture in 2026 is defined by a cost shock. In late 2025 Molina reported a surprise quarterly loss and cut 2026 adjusted earnings guidance dramatically (to at least ~$5.00 per share from prior expectations above ~$14), and the stock fell roughly 28%. The core problem is that medical utilization and retroactive Medicaid adjustments outran the rates states were paying, pushing the medical care ratio into the low 90s percent. Q1 2026 showed an adjusted earnings beat but a still-elevated cost ratio, plus a charge tied to exiting an underperforming Medicare Part D product for 2027. Bulls see a cyclical margin recovery as states re-rate contracts higher; the risk is that elevated costs persist and compress margins for longer.

The central risk is that elevated medical utilization and retroactive Medicaid adjustments keep outpacing state rate increases, keeping the medical care ratio high and margins compressed longer than expected. Molina is heavily exposed to political and regulatory decisions: potential cuts to Medicaid funding, changes to ACA Marketplace subsidies, and eligibility redeterminations can each shrink membership or reimbursement. Revenue concentration in a handful of large state contracts means losing a re-procurement can be material. The 2026 guidance cut and prior loss show earnings can swing sharply and unpredictably. Competition from larger, better-capitalized insurers (Centene, UnitedHealth, Elevance, Humana, CVS/Aetna) pressures bids and margins.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Molina Healthcare Inc's investor relations page or your broker.

• Revenue (TTM): ~$43B
• 2026 premium revenue (guided): ~$42B
• 2026 adjusted EPS (guided): at least ~$5.00
• Q1 2026 medical care ratio: ~91%
• Market cap: ~$12B
• Members: ~5.6M

MOH shares fell roughly 28% in early 2026 after a surprise quarterly loss and a steep cut to 2026 adjusted earnings guidance. The reported P/E looks distorted (very high on depressed trailing GAAP earnings, lower on forward views), so the market is valuing it on a hoped-for margin recovery rather than trailing profits. The key metric to watch is the medical care ratio versus state rate updates.

There are three common ways to get MOH exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so MOH sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where MOH fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

MOH is a Medicaid-focused insurer working through a medical-cost squeeze, where the investment case hinges on whether rate increases catch up to utilization.

Whether MOH is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MOH a buy?, and where the stock could go from here in the MOH stock forecast.

For income investors, whether MOH pays a dividend and how the payout looks is covered in does MOH pay a dividend?